Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001422849-16-000691
Filing Date
2016-02-16
Accepted
2016-02-12 17:33:20
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G edgxene.txt SC 13G 7633
  Complete submission text file 0001422849-16-000691.txt   9125
Mailing Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071 213-486-9200
Capital World Investors (Filed by) CIK: 0001422849 (see all company filings)

EIN.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Subject) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88403 | Film No.: 161421156
SIC: 2834 Pharmaceutical Preparations